Press Release Summary:
HyClone AdvanceSTEM(TM) stem cell culture products support expansion and maintenance of undifferentiated murine embryonic and human adult mesenchymal stem cells to directed differentiation of mesenchymal stem cells into adipocytes, chondrocytes, and osteocytes. HyClone AdvanceSTEM(TM) Serum Replacement supports growth of undifferentiated embryonic stem cells in culture with minimal or no need for fetal bovine serum supplementation, while AdvanceSTEM(TM) Low Osmo DMEM features optimized osmolarity.
Original Press Release:
Thermo Fisher Scientific Launches New Line of Cell Culture Products to Advance Stem Cell Research
LOGAN, Utah, (June 28, 2007) - Thermo Fisher Scientific Inc., the world leader in serving science, has announced the launch of its Thermo Scientific HyClone AdvanceSTEM(TM) product Line.
Utilizing expertise gained during 40 years as a leading cell culture supplier, the HyClone AdvanceSTEM(TM) line of stem cell culture products has been developed specifically for applications in stem cell research. The line comprises numerous products designed to support a wide range of applications such as the expansion and maintenance of undifferentiated murine embryonic and human adult mesenchymal stem cells to the directed differentiation of mesenchymal stem cells into adipocytes, chondrocytes and osteocytes.
The line includes HyClone AdvanceSTEM(TM) Serum Replacement, which has been developed to support the growth of undifferentiated embryonic stem cells in culture with minimal or no requirement for fetal bovine serum supplementation; and HyClone AdvanceSTEM(TM) Low Osmo DMEM, which features an optimized osmolarity (osmo) approximating that of murine embryonic tissue.
The HyClone AdvanceSTEM(TM) line also includes its popular ES-Screened Fetal Bovine Serum, which is screened for the ability to promote the rapid growth of ES cells while retaining their pluripotent abilities. This eliminates the need for prescreening serum, saving researchers precious time and money while providing the assurance that the serum used has been screened by experienced ES cell culturists.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.